Skip to main content
. 2022 May 27;11(11):3016. doi: 10.3390/jcm11113016

Table S2.

Genotypes and phenotypes of patients with disease-causing mutations.

Gene Patient ID Mutations Age at Onset (Years) Sex b Family History Mode of Onset Kidney Biopsy Renal Outcome Time to ESRD (Years)
WT1 (REFSEQ: NM_024426.5)
SRNS-20 c.1400G > A, p.R467Q At birth M N NS ND ESRD 0.1
SRNS-42 c.1136delT, p.V379Dfs a 6.5 M N PU FSGS ESRD 2.7
SRNS-126 c.1231C > T, p.H411Y a 1.5 F N NS FSGS ESRD 7.3
SRNS-151 c.1315C > T, p.R439C At birth M N NS ND ESRD 0.0
SRNS-156 c.760C > A, p.P254T a 3.3 M N NS FSGS ESRD 6.1
SRNS-186 c.1363C > T, p.P455S 8.0 M Y NS FSGS Normal eGFR NA
SRNS-222 c.1316G > A, p.R439H At birth M N NS FSGS ESRD 0.4
SRNS-223 c.1316G > A, p.R439H At birth F N NS DMS ESRD 0.0
SRNS-224 c.1316G > A, p.R439H At birth F N NS FSGS Death NA
SRNS-225 c.1316G > A, p.R439H At birth F N NS ND ESRD 0.0
SRNS-226 c.1316G > C, p.R439P At birth M NA PU ND ESRD 1.8
SRNS-227 c.1315C > T, p.R439C At birth F N NS ND ESRD 0.0
SRNS-228 c.1324C > A, p.Q442K 1.0 F N ESRD ND ESRD 0.0
SRNS-229 c.1372T > A, p.C458S At birth M N NS DMS ESRD 1.1
SRNS-230 c.1399C > T, p.R467W At birth M N PU DMS ESRD 1.8
SRNS-231 c.1405G > T, p.D469Y At birth F NA NS DMS ESRD 0.0
SRNS-232 c.785 − 1G > C in intron 2 a NA M NA NA ND NA NA
SRNS-233 c.1447 + 4C > T in intron 9 6.6 F N NS FSGS CKD NA
SRNS-234 c.1447 + 4C > T in intron 9 2.6 F N NS FSGS Normal eGFR NA
SRNS-235 c.1447 + 4C > T in intron 9 3.5 M N ESRD ND ESRD 0.0
SRNS-236 c.1447 + 4C > T in intron 9 6.8 M N NS MesPGN ESRD 15.4
SRNS-237 c.1447 + 4C > T in intron 9 At birth F N CKD ND ESRD 0.7
SRNS-238 c.1447 + 5G > A in intron 9 At birth M N PU FSGS ESRD 19.7
SRNS-239 c.1447 + 5G > A in intron 9 5.0 F N NS FSGS ESRD 4.2
SRNS-240 c.1447 + 5G > A in intron 9 6.8 F N PU FSGS ESRD 12.9
SRNS-241 c.1447 + 5G > A in intron 9 11.4 M N CKD FSGS ESRD 0.3
SRNS-242 c.1447 + 5G > A in intron 9 12.3 M N PU FSGS Normal eGFR NA
SRNS-243 c.1419_1430del12, p.H474_T477del a At birth M N ESRD ND ESRD 0.0
SRNS-244 c.1381T > C, p.C461R 2.2 F N ESRD MesPGN ESRD 0.0
SRNS-245 c.1297T > C, p.C433R At birth F N ESRD ND ESRD 0.0
COQ6 (REFSEQ: NM_182476.2)
SRNS-61 c.686A > C, p.Q229P
c.782C > T, p.P261L
1.1 M N PU FSGS Normal eGFR NA
SRNS-103 c.124G > T, p.G42C a
c. 782C > T, p.P261L
At birth F N NS FSGS ESRD 0.4
SRNS-203 c.484C > T, p.R162*
c.782C > T, p.P261L
9.1 M N PU FSGS ESRD 0.8
SRNS-251 c.189_191del3, p.K64del
c.782C > T, p.P261L
3.9 M N NS FSGS ESRD 2.2
SRNS-252 c.189_191del3, p.K64del
c.686A > C, p.Q229P
2.0 F N NS FSGS ESRD 1.1
SRNS-253 c.189_191del3, p.K64del
c.782C > T, p.P261L
3.9 F N NS FSGS ESRD 0.1
SRNS-254 c.189_191del3, p.K64del
c.782C > T, p.P261L
2.7 F N NS FSGS ESRD 1.9
SRNS-255 c.189_191del3, p.K64del
c.782C > T, p.P261L
1.2 F Y NS FSGS ESRD 0.1
SRNS-256 c.189_191del3, p.K64del
c.782C > T, p.P261L
3.1 M N NS FSGS ESRD 0.4
SRNS-257 c.686A > C, p.Q229P
c.782C > T, p.P261L
At birth M N NS FSGS ESRD 1.7
SRNS-258 c.189_191del3, p.K64del
c.782C > T, p.P261L
1.1 M N NS FSGS ESRD 0.2
NPHS1 (REFSEQ: NM_004646.3)
SRNS-85 c.2156_2163del8, p.L719Pfs*4
c.2464G > A, p.V822M
At birth F Y NS MesPGN Death 0.0
SRNS-206 c.2156_2163del8, p.L719Pfs*4
c.3250dupG, p.V1084Gfs*12
At birth M N NS MesPGN ESRD 2.5
SRNS-207 c.2442C > G, p.Y814*
c.1379G > A, p.R460Q
At birth F N NS ND ESRD 3.0
SRNS-208 c.188A > G, p.Q63R
c.1885G > T, p.E629*
At birth M N NS FSGS ESRD 1.6
SRNS-209 c.3027C > G, p.Y1009*
c.3478C > T, p.R1160*
At birth F N NS ND ESRD 3.2
SRNS-210 c.2765C > A, p.A922D
c.3287 − 11G > A in intron 24
At birth M N NS FSGS CKD NA
SRNS-211 c.2156_2163del8, p.L719Pfs*4
c.3478C > T, p.R1160*
At birth M N NS ND ESRD 4.7
SRNS-212 c.58 + 2T > C in intron 1 a
c.1338delT, p.I466Mfs*16 a
At birth F Y NS MesPGN ESRD 1.5
SRNS-213 c.526 + 1G > A in intron 4
c.1632_1634del3, p.545del
At birth M N NS ND Normal eGFR NA
SRNS-214 c.3213dupG, p.L1072Afs*24 a
c.3478C > T, p.R1160*
At birth M N NS ND Death 0.0
SRNS-215 c.139delG, p.A47Pfs*81 (homozygote) At birth M N NS MesPGN ESRD 1.8
NUP107 (REFSEQ: NM_020401.3)
SRNS-71 c.934delT, p.Y312Tfs a
c.2492A > C, p.D831A
4.8 M N PU FSGS ESRD 8.7
SRNS-259 c.2071C > T, p.Q691*
c.2492A > C, p.D831A
4.3 M Y NS FSGS ESRD 4.2
SRNS-260 c.627_663dup37, p.L225Ffs*15 a
c.2492A > C, p.D831A
3.8 F N PU FSGS ESRD 3.0
SRNS-261 c.1079_1083del5, p.E360Gfs*6
c.2492A > C, p.D831A
3.4 M Y NS FSGS ESRD 2.0
SRNS-262 c.1079_1083de5l, p.E360Gfs*6
c.2492A > C, p.D831A
2.4 M N PU FSGS ESRD 2.7
SRNS-263 c.1079_1083del5, p.E360Gfs*6
c.2492A > C, p.D831A
3.8 M N ESRD ND ESRD 0.0
SRNS-264 c.469G > T, p.D157Y
c.2492A > C, p.D831A
10.9 F Y CKD FSGS ESRD 2.1
SRNS-265 c.1079_1083del5, p.E360Gfs*6
c.2492A > C, p.D831A
4.0 F N ESRD ND ESRD 0.0
SRNS-266 c.2492A > C, p.D831A
c.1735 − 3T > G in intron 20
4.1 M Y PU FSGS ESRD 7.4
COQ8B (REFSEQ: NM_024876.3)
SRNS-25 c.759C > A, p.N253K (homozygote) 1.1 F NA NS FSGS ESRD 1.5
SRNS-35 c.737G > A, p.S246N
c.532C > T, p.R178W
6.7 M N PU FSGS CKD NA
SRNS-93 c.737G > A, p.S246N
c.1548C > A, p.Y516* a
9.9 F N PU FSGS Normal eGFR NA
SRNS-246 c.449G > A, p.R150Q
c.759C > A, p.N253K
5.1 M Y PU FSGS ESRD 5.1
SRNS-247 c.737G > A, p.S246N
c.759C > A, p.N253K
10.8 F N PU FSGS ESRD 2.0
SRNS-248 c.737G > A, p.S246N (homozygote) 9.2 F N PU FSGS ESRD 3.0
SRNS-249 c.737G > A, p.S246N
c.1468C > T, p.R490C
6.9 F N PU FSGS ESRD 3.9
SRNS-250 c.737G > A, p.S246N (homozygote) 13.0 F N PU FSGS Normal eGFR NA
MYH9 (REFSEQ: NM_002473.5)
SRNS-205 c.3494G > T, p.R1165L 16.8 F Y PU ND ESRD 17.5
SRNS-273 c. 2152C > T, p.R718W 1.3 M N NS MesPGN ESRD 5.3
SRNS-274 c.287C > T, p.S96L 20.0 M N PU FSGS ESRD 0.7
SRNS-275 c.287C > T, p.S96L 12.1 F N PU ND ESRD 8.3
SRNS-276 c.2104C > T, p.R702C 8.7 F NA PU MesPGN ESRD 7.8
SRNS-277 c.287C > T, p.S96L 12.4 M NA PU MesPGN ESRD 10.5
INF2 (REFSEQ: NM_022489.3)
SRNS-63 c.233T > G, p.L78R a 11.0 M N PU FSGS ESRD 6.7
SRNS-69 c.658G > A, p.E220K 11.1 F N PU FSGS ESRD 4.0
SRNS-268 c.658G > A, p.E220K 7.4 M Y PU FSGS ESRD 5.8
SRNS-269 c.658G > A, p.E220K 11.7 M N NS FSGS ESRD 5.5
SRNS-270 c.230T > C, p.L77P 9.2 F N NS FSGS ESRD 3.4
SRNS-271 c.529C > T, p.R177C 12.6 F Y PU FSGS Normal eGFR NA
PAX2 (REFSEQ: NM_003987.4)
SRNS-26 c.76dupG, p.V26Gfs*28 5.3 M N PU FSGS ESRD 10.2
SRNS-31 c.563A > G, p.N188S a 3.4 M N NS ND Normal eGFR NA
SRNS-32 c.222_225dup4, p.G76Dfs a 13.4 M Y PU FSGS CKD NA
SRNS-95 c.74G > A, p.G25E a 7.2 F N PU FSGS ESRD 7.3
SRNS-191 c.419G > A, p.R140Q 7.8 M N PU FSGS Normal eGFR NA
NPHS2 (REFSEQ: NM_014625.3)
SRNS-27 c.503G > A, p.R168H
c.467dupT, p.L156Ffs*11
1.3 F NA NS ND ESRD 3.6
SRNS-47 c.412C > T, p.R138*
c.503G > A, p.R168H
2.1 M N NS FSGS ESRD 4.9
SRNS-136 c.502C > T, p.R168C
c.851C > T, p.A284V
6.9 M N PU FSGS CKD NA
SRNS-216 c.358T > C, p.S120P
c.503G > A, p.R168H
At birth M N NS FSGS ESRD 8.4
COL4A5 (REFSEQ: NM_000495.4)
SRNS-49 c.834 + 1G > A in intron 14 10.0 F Y PU FSGS CKD NA
SRNS-81 c.956G > A, p.G319D 10.1 M Y PU FSGS ESRD 10.1
SRNS-87 c.4946delT, p.L1649Rfs*4 a 12.9 M Y PU FSGS ESRD 6.7
SRNS-120 c.1165 + 1G > A in intron 19 3.8 M N NS FSGS ESRD 6.7
SRNS-134 c.4082T > A, p.L1361* a 14.0 M Y PU FSGS ESRD 8.4
SRNs-190 c.4532G > A, p.R1511H 12.8 M N PU FSGS CKD NA
COL4A4 (REFSEQ: NM_000092.4)
SRNS-53 c.1111delG, p.D371Tfs a
c.1323_1340del18, p.P444_L449del
0.8 F Y PU MesPGN ESRD 18.9
SRNS-148 c.2630G > A, p.R877Q 3.6 M N NS ND Death 2.3
SRNS-152 c.1046G > A, p.R349Q a 2.5 F N NS FSGS Normal eGFR NA
SRNS-181 c.2630G > A, p.R877Q 14.3 F N PU FSGS Normal eGFR NA
MAFB (REFSEQ: NM_005461.4)
SRNS-204 c.194G > T, p.S65I 9.8 M Y PU ND Normal eGFR NA
SRNS-280 c.183C > A, p.S61R 12.5 F N PU FSGS CKD NA
SRNS-281 c.211C > G, p.P71A 4.4 M N PU FSGS ESRD 0.6
SRNS-282 c.212C > T, p.P71L 1.2 M N PU ND Normal eGFR NA
LAMB2 (REFSEQ: NM_002292.3)
SRNS-217 c.1503_1504delAT, p.C502*
c.4267delT, p.C1423Vfs*29
0.7 F N NS FSGS ESRD 10.8
SRNS-218 c.2283-2286del4, p.S762Rfs*29
c.536C > T, p.S179F
At birth F N NS FSGS CKD NA
SRNS-219 c.474delT, p.A159Pfs*33 a
c.1328_1329del2, p.H443Rfs*11 a
At birth F N NS ND ESRD 0.1
WDR19 (REFSEQ: NM_025132.3)
SRNS-289 c.3533G > A, p.R1178Q
c.3703G > A, p.E1235K
9.6 M N PU FSGS ESRD 1.4
SRNS-290 c.3533G > A, p.R1178Q
c.3703G > A, p.E1235K
6.2 F Y PU MesPGN ESRD 3.0
SRNS-291 c.1853T > C, p.L618P
c.3533G > A, p.R1178Q
At birth M N CKD ND ESRD 0.3
SMARCAL1 (REFSEQ: NM_014140.3)
SRNS-144 c.1682G > A, p.R561H
c.1851 + 1G > T in intron 9 a
6.0 M N NS FSGS ESRD 3.4
SRNS-287 c.1411dupA, p.I471Nfs a
c.1484A > C, p.Q495P a
5.5 F N NS FSGS ESRD 1.5
SRNS-288 c.1484A > C, p.Q495P a
c.1851 + 1G > T in intron 9 a
3.5 M N PU FSGS ESRD 2.1
MT-TL1 (REFSEQ: NC_012920)
SRNS-284 mtDNA3243A > G 18.9 F Y PU DMS CKD NA
SRNS-285 mtDNA3243A > G 11.8 F Y PU FSGS ESRD 6.0
SRNS-286 mtDNA3243A > G 9.8 F N PU FSGS ESRD 5.3
FOXP3 (REFSEQ: NM_014009.3)
SRNS-283 c.736 − 2A > G in intron 7 a 3.4 M N NS MNP Normal eGFR NA
ACTN4 (REFSEQ: NM_004924.5)
SRNS-267 c.785C > T, p.S262F 3.5 M Y NS FSGS ESRD 1.2
LMX1B (REFSEQ: NM_002316.3)
SRNS-279 c. 668G > A, p.R223Q 2.1 F N NS FSGS ESRD 1.86
ANLN (REFSEQ: NM_018685.4)
SRNS-65 c.2305A > T, p.L769* a 7.7 M N PU FSGS Normal eGFR NA
TRPC6 (REFSEQ: NM_004621.5)
SRNS-37 c.523C > G, p.R175G a 8.5 F N PU FSGS ESRD 2.3
COL4A3 (REFSEQ: NM_000091.4)
SRNS-199 c.4793T > G, p.L1598R 0.5 F N NS DMS ESRD 0.9
TP53RK (REFSEQ: NM_033550.3)
SRNS-221 c.194A > T, p.K65M (homozygote) At birth F NA NA ND Death 0.0
DGKE (REFSEQ: NM_003647.2)
SRNS-272 c.501C > G, p.C167W
c.610dupA, p.T204Nfs*4
0.5 M N PU FSGS CKD NA
LCAT (REFSEQ: NM_000229.1)
SRNS-278 c.794_801del8, p.E265Afs*18
c.931delT, p.F311Lfs*99 a
9.6 M Y PU FSGS Normal eGFR NA
COQ2 (REFSEQ: NM_015697.7)
SRNS-168 c.392A > G, p.D131G a
c.518G > A, p.R173H a
At birth F N NS FSGS ESRD 0.3
PODXL (REFSEQ: NM_005397.3)
SRNS-220 c.3G > T, p.M1?
c.926G > A, p.W309*
At birth M Y NS ND ESRD 0.0

a Novel mutations. b Sex of patients with WT1 mutations and sex reversal, followed by their karyotypes. NA, not available; ND, not done; NS, nephrotic syndrome; PU, proteinuria; CKD, chronic kidney disease; ESRD, end-stage renal disease; eGFR, estimated glomerular filtration rate; FSGS, focal segmental glomerulosclerosis; DMS, diffuse mesangial sclerosis; MesPGN, mesangial proliferative glomerulonephritis; MNP, membranous nephropathy; M, male; F, female; Y, yes; N, no.